Fitzgerald Meghaninsider trades
In SEC Form 4 filings, Fitzgerald Meghan is listed as Director of Roivant Sciences Ltd. (ROIV). In the last 90 days, Fitzgerald Meghan sold $1.00M of Roivant Sciences Ltd. (ROIV) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ROIVRoivant Sciences Ltd. | Director | 8 | Sep 18 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-10
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ROIVRoivant Sciences Ltd. | Sep 16 | Sep 18 | A | 5,054 | $0.00 | $0 | 41,162 | No | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 16 | Sep 18 | A · derivative | 10,531 | $39.57 | $416,712 | 10,531 | No | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 15 | Sep 17 | S | 4,712 | $39.68 | Sale −$186,972 | 36,508 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 15 | Sep 17 | S | 400 | $40.45 | Sale −$16,180 | 36,108 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 10 | Sep 14 | F | 1,743 | $40.94 | $71,358 | 41,220 | No | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 8 | Sep 10 | M | 20,000 | $8.80 | $176,000 | 62,963 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 8 | Sep 10 | S | 20,000 | $39.90 | Sale −$798,000 | 42,963 | Yes | Form 4 |
| ROIVRoivant Sciences Ltd. | Sep 8 | Sep 10 | M · derivative | 20,000 | $8.80 | $176,000 | 18,578 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.